hg_57064.1

Basic information about the TSS

---

TSS ID: hg_57064.1 Species: human Chr: chr5		Start: 74685140 End: 74685151 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK130002 Distance: 0 GeneID: 3074 HGNC/MGI_ID: HGNC:4879 UniProt_ID:

Gene_name: hexosaminidase subunit beta Gene_symbol: HEXB Gene_synonyms: Gene_source: HGNC:4879

TATA-Box annotation

---

Distance to TSS:	-87
Nearest PromoterID:	NM_000521
Entrez ID:	3074
Nearest Unigene:	Hs.69293
Nearest Refseq:	NM_000521
Nearest Ensembl:	ENSG00000049860
Gene Name:	hexosaminidase subunit beta
Gene Alias:	ENC-1AS|HEL-248|HEL-S-111
Gene Description:	hexosaminidase subunit beta
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.736318
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HEXB p2@HEXB p3@HEXB p4@HEXB p5@HEXB p6@HEXB
Sample		p1@HEXB	p2@HEXB	p3@HEXB	p4@HEXB	p5@HEXB	p6@HEXB
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.74	12.27	6.62	0.97	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.51	13.76	7.89	2.43	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.35	13.50	6.75	2.12	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.64	10.81	7.07	1.04	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.27	18.45	7.20	1.12	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	11.82	13.95	6.98	0.78	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	24.40	13.07	9.37	0.22	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.78	12.35	8.24	1.45	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.31	18.38	9.40	0.43	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	9.27	5.22	1.16	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.74	10.91	6.47	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	9.35	6.50	1.22	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.11	42.72	36.27	2.10	1.29	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.91	36.99	22.55	0.60	0.90	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.17	29.64	29.64	0.88	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.89	31.94	27.16	1.01	1.51	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.84	29.92	27.08	1.31	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.56	36.70	21.51	2.11	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	26.66	19.73	1.60	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.07	33.10	30.99	1.65	1.20	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.26	37.56	28.74	1.34	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.58	34.18	25.55	0.52	0.69	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.65	30.25	23.78	1.29	0.78	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	23.30	35.43	24.99	1.70	1.46	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.28	37.41	25.80	2.58	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.79	36.40	30.39	2.53	0.63	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.03	26.92	19.23	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.40	37.72	32.77	1.41	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	24.23	37.31	22.45	2.26	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.07	35.47	27.51	1.63	1.09	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.35	34.75	24.91	1.47	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.42	35.17	24.62	1.56	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.47	29.54	18.36	0.84	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	19.79	20.95	16.99	1.15	0.16	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.75	28.42	28.24	1.87	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	24.14	36.98	29.13	1.34	1.34	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.59	32.29	25.14	1.23	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.75	31.43	21.16	2.01	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.23	30.79	23.50	1.08	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	20.89	30.25	23.29	1.92	0.96	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.53	32.23	22.11	1.41	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.03	20.79	19.03	1.02	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.05	31.21	24.04	0.63	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.10	33.04	29.90	2.80	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	26.50	28.71	22.69	2.01	1.00	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	26.52	28.15	1.40	0.23	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.95	35.03	26.39	1.68	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.04	29.81	29.51	0.89	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	29.20	33.51	25.13	2.87	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.05	24.47	21.03	0.40	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	22.75	28.69	25.62	1.64	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	21.79	32.91	26.24	0.89	0.89	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	41.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.74	30.87	17.74	1.06	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	25.85	20.21	2.65	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	8.39	10.07	1.68	0.00	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.53	13.32	15.15	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.74	19.45	18.80	1.94	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.09	19.27	18.95	0.96	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.55	15.72	11.63	0.63	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	16.22	17.63	7.76	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.02	15.14	14.02	1.12	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	5.57	3.98	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.57	12.91	9.51	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.02	19.50	15.27	0.32	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.62	11.00	9.58	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	8.78	10.24	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	10.41	14.38	0.00	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	8.91	8.91	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	10.27	16.56	17.88	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	10.52	19.49	14.23	0.62	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.87	19.26	16.82	0.00	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	37.54	29.62	31.68	1.74	0.63	0.32
Adipocyte - breast, donor2	11327-117E4	29.84	17.97	15.08	2.25	0.64	1.44
Adipocyte - omental, donor1	11473-119C6	35.50	34.35	29.90	2.67	0.76	0.00
Adipocyte - omental, donor2	11474-119C7	26.16	26.16	17.94	0.75	0.00	2.24
Adipocyte - omental, donor3	11475-119C8	26.79	21.77	22.77	0.67	1.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	32.54	34.45	21.05	4.47	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	4.40	5.50	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	12.65	13.10	9.94	0.90	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.12	14.60	9.04	1.39	0.17	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	72.56	46.94	48.50	1.76	1.17	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	59.20	25.22	26.25	1.54	1.29	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	93.67	33.73	43.21	1.12	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	35.27	27.04	25.28	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	40.38	17.21	20.35	0.80	0.48	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	105.22	36.79	33.24	1.94	1.61	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	46.39	16.53	15.46	2.13	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	13.35	9.46	1.67	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	9.98	9.15	1.25	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	71.58	26.12	22.10	3.27	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	28.80	11.78	8.84	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	9.13	9.44	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	7.51	6.41	4.86	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	1.43	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	6.48	9.71	4.86	0.36	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	3.35	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.96	8.63	8.83	0.21	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	20.25	23.69	15.10	2.40	0.23	0.46
Anulus Pulposus Cell, donor2	11463-119B5	10.78	19.59	9.80	1.71	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	13.93	5.84	0.00	0.00	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.27	21.71	8.68	1.74	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	12.84	10.70	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.22	14.05	10.76	0.00	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	17.71	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.76	10.56	8.58	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	28.27	14.94	8.77	0.65	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.27	18.45	9.22	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	11.88	5.94	1.78	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.10	14.31	9.79	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	13.79	10.89	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	7.52	10.03	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.66	19.11	16.31	0.66	0.99	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	8.19	15.01	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	29.71	13.27	10.71	0.75	0.30	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.65	12.32	9.11	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.86	19.08	8.69	0.38	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.65	13.10	11.76	1.34	0.27	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	26.34	13.66	14.63	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.40	12.94	11.28	0.17	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	8.41	7.20	1.20	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	17.70	14.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.81	13.55	9.09	0.69	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	4.19	4.19	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.30	13.11	12.62	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.15	19.73	12.14	0.38	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	3.63	4.85	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.37	14.82	9.69	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	25.44	19.45	10.05	0.64	0.21	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	25.29	11.87	11.10	0.00	0.00	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.21	8.91	9.85	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.19	17.36	9.00	0.96	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.98	8.56	10.70	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.72	14.62	7.02	0.58	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.78	13.25	11.74	0.30	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	14.26	9.50	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.95	14.24	9.66	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	17.06	11.21	0.25	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	22.87	12.71	10.17	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	12.08	11.65	2.16	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.07	12.07	8.26	1.06	0.42	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.14	12.18	9.28	1.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	19.84	10.39	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	22.72	11.70	10.51	0.68	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	13.90	6.95	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	27.46	12.68	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	20.58	13.72	8.36	0.43	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	8.42	5.41	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	13.85	6.56	0.73	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.67	17.01	5.98	0.46	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	31.52	21.10	10.17	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.57	15.07	8.88	0.41	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.42	10.40	11.63	0.00	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.42	11.47	10.99	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	24.39	14.86	7.10	0.22	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	16.78	9.15	12.21	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.14	12.74	4.43	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.86	13.50	8.21	1.06	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.17	11.63	8.72	0.00	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	6.14	7.61	6.02	0.25	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	4.79	5.13	3.94	0.86	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	1.68	4.40	3.15	0.42	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	9.76	17.43	11.85	2.09	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	13.91	17.31	8.25	0.32	0.81	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	13.87	20.58	13.42	0.89	0.45	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	6.08	16.06	5.28	1.72	0.46	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	5.51	10.02	6.14	0.63	0.63	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.35	10.47	4.67	0.80	0.34	0.00
Basophils, donor1	12241-129G9	51.00	4.45	11.25	0.00	0.00	0.00
Basophils, donor2	12242-129H1	66.75	11.55	17.32	0.72	0.00	0.00
Basophils, donor3	12243-129H2	88.35	20.14	31.90	0.73	0.59	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	7.55	3.23	1.08	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	5.03	3.66	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	10.04	3.77	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.85	7.49	6.45	0.83	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.30	6.68	7.14	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	8.28	18.35	7.92	0.90	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.66	7.45	2.10	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.22	20.15	18.55	1.28	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	62.05	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	91.86	16.91	35.50	0.56	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	64.03	15.78	17.63	0.19	0.37	0.56
CD14+ Monocytes, donor3	11381-118B4	63.01	14.05	25.25	0.66	0.88	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	345.88	85.48	123.97	6.51	3.11	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	354.43	75.06	116.38	6.82	6.82	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	335.97	82.19	98.29	4.93	1.97	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	122.14	12.58	30.07	0.29	0.72	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	113.46	12.07	30.17	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	121.53	10.19	23.22	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	90.39	10.04	22.43	0.33	0.17	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	104.06	8.56	24.01	0.00	0.55	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	115.78	8.18	22.31	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	67.55	8.81	18.99	0.20	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	76.56	13.53	20.65	0.36	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	95.76	10.23	17.41	0.00	0.44	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	100.21	8.66	25.29	0.00	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	113.00	12.67	27.46	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	88.75	7.77	18.86	0.00	0.00	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	109.48	14.73	27.67	0.45	0.74	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	102.57	11.57	27.94	0.20	0.20	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	157.82	7.91	24.15	0.42	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	96.78	14.18	22.88	0.46	0.46	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	125.09	10.86	24.20	0.23	0.68	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	80.75	4.80	14.40	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	55.14	9.95	20.71	0.00	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	94.03	14.13	25.12	0.17	0.70	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	73.64	8.42	18.52	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	70.36	9.55	20.02	0.37	0.73	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	55.31	8.45	15.85	0.00	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	79.41	5.70	15.36	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	95.38	10.46	21.97	0.17	1.05	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	99.61	10.78	15.61	0.00	0.37	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	142.48	14.87	22.42	0.43	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	69.20	8.19	11.88	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	82.29	7.88	11.82	0.70	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	71.69	7.66	12.53	0.46	0.00	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	60.16	9.59	16.57	0.22	0.44	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	54.28	15.94	18.71	0.23	0.46	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	76.68	11.70	23.61	1.52	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	154.63	28.65	52.79	0.93	2.02	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	138.32	25.50	49.25	0.35	0.87	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	115.05	20.07	39.91	0.22	1.11	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	34.45	10.97	11.99	0.51	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	30.96	8.56	14.93	0.22	0.66	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	27.16	10.74	15.58	0.63	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	14.23	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	7.46	23.05	8.81	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	9.32	10.36	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	11.19	6.93	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	6.97	12.33	4.82	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	8.42	17.55	2.81	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	10.20	10.98	7.06	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	19.77	6.59	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	14.79	9.04	3.29	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	11.61	7.98	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	13.13	15.65	3.53	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.85	11.31	5.25	1.62	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.19	13.58	4.79	2.00	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	12.05	13.05	11.04	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	21.35	5.06	6.74	1.12	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	35.70	19.92	19.92	1.50	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	29.31	21.42	17.59	1.35	0.90	0.23
CD4+ T Cells, donor1	11225-116C1	10.35	16.78	8.57	0.71	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	6.74	14.08	8.57	0.61	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	8.84	11.28	6.10	0.00	0.30	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.55	15.57	13.27	0.77	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	16.62	15.72	9.43	0.90	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	20.12	11.79	8.91	0.86	0.86	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	7.59	16.12	8.06	1.42	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	12.64	31.60	5.62	1.40	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	3.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.19	18.64	7.51	1.30	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.22	12.88	8.64	0.17	0.34	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	13.38	14.02	8.22	0.32	0.16	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.07	17.93	6.72	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.78	20.96	6.29	1.05	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	12.32	11.44	5.28	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	17.29	8.85	5.48	1.26	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.05	11.43	6.86	1.25	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.03	9.02	7.02	0.33	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.79	17.40	7.34	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.61	18.22	8.58	1.07	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	5.38	5.38	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.72	21.32	11.87	0.37	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	14.51	16.90	10.18	0.65	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	17.86	21.02	15.55	0.00	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	12.64	17.19	10.11	1.01	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.96	18.20	8.67	1.30	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	11.77	11.77	10.90	1.31	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.79	15.34	12.87	0.99	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	9.23	24.00	13.85	2.77	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	19.54	15.35	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	15.51	12.18	5.54	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.06	8.59	8.10	0.25	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	20.02	13.86	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	17.19	16.12	16.12	0.00	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	16.62	13.85	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	10.80	13.42	4.91	0.65	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	12.01	14.64	6.38	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	7.07	9.59	4.54	0.50	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.59	10.55	5.05	0.92	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.79	6.23	4.31	0.48	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	8.48	4.38	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.80	4.50	3.90	1.20	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	8.40	4.56	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.59	10.69	3.87	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	10.00	3.91	0.22	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.16	5.26	4.21	0.53	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.99	11.26	3.05	0.47	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.23	6.94	6.94	0.60	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	7.26	6.68	4.94	0.29	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	8.53	5.33	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.06	6.13	1.31	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.64	4.10	5.01	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.98	4.48	2.98	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	5.40	6.12	5.76	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	4.89	8.63	4.32	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.95	10.13	5.89	0.71	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.92	11.09	3.80	0.95	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	9.23	4.00	0.62	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.13	7.69	4.81	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	5.74	9.56	4.59	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	5.52	9.85	4.34	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	6.81	5.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	11.24	8.83	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	3.50	7.69	9.09	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	6.01	6.01	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	3.66	3.66	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	22.23	13.34	5.93	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	18.42	15.36	10.84	0.32	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	24.27	18.03	13.52	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	16.70	10.31	12.08	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	22.76	20.25	18.09	0.91	0.57	0.46
Chondrocyte - re diff, donor2	11339-117F7	77.89	35.81	40.29	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	21.43	16.98	23.86	0.81	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	15.95	24.44	15.15	2.07	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	16.67	17.32	10.47	0.64	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	14.78	20.09	11.33	0.27	0.44	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	27.88	25.31	15.77	2.57	1.10	0.00
Corneal Epithelial Cells, donor1	11526-119I5	3.51	7.25	5.49	0.00	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	9.10	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.81	6.39	4.35	0.26	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	146.77	49.36	81.06	3.47	1.16	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	173.48	56.14	88.63	4.10	3.15	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	34.51	51.76	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	131.32	46.76	70.95	1.62	2.16	2.38
Dendritic Cells - plasmacytoid, donor1	11228-116C4	41.34	46.12	30.06	1.71	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	48.97	30.68	25.46	0.65	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	36.78	34.36	17.91	1.94	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	33.85	5.84	6.67	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	26.40	6.45	9.39	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	28.28	3.96	9.90	0.28	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	40.10	2.75	8.26	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	29.67	3.78	3.49	0.29	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.35	6.12	8.23	0.47	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	26.65	5.96	6.31	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	74.92	11.30	22.83	0.44	1.55	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	92.19	17.65	20.99	0.91	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	68.50	11.84	17.76	0.00	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	16.05	4.75	5.65	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	4.17	9.37	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.17	5.25	5.25	0.00	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	34.41	6.80	8.80	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	5.77	3.67	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	76.78	18.39	19.38	0.75	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	39.76	11.51	10.21	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	41.16	8.06	11.72	0.12	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	29.58	3.41	3.41	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.73	4.19	5.59	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.42	8.01	10.52	0.00	0.31	0.63
Eosinophils, donor1	12244-129H3	30.49	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	42.91	9.90	9.90	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	78.47	10.70	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.66	7.09	2.44	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.14	13.14	9.44	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.79	23.98	25.73	1.20	0.55	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	2.49	6.07	3.90	0.22	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.32	22.07	20.74	1.09	0.36	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	67.28	35.21	39.85	3.28	0.96	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.45	28.69	21.94	0.84	0.74	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	82.47	56.65	45.32	5.27	2.11	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.87	28.90	26.58	1.33	1.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	17.69	7.26	5.44	0.45	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	7.58	4.55	6.06	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.30	11.99	9.94	0.79	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	31.83	22.73	20.61	0.91	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	27.16	14.47	12.82	0.38	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	31.83	16.22	14.86	0.00	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	16.08	11.26	9.51	0.94	0.80	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.81	12.51	8.20	1.29	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	19.04	14.65	16.11	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.30	12.22	7.61	0.46	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	47.83	54.10	32.22	2.88	0.51	0.34
Fibroblast - Dermal, donor1	11269-116G9	28.17	26.06	13.62	1.88	1.41	0.00
Fibroblast - Dermal, donor2	11346-117G5	22.17	12.74	14.62	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	20.19	29.86	19.46	0.60	0.60	0.85
Fibroblast - Dermal, donor4	11450-119A1	15.26	20.01	10.85	1.24	0.57	0.00
Fibroblast - Dermal, donor5	11454-119A5	16.75	17.62	9.25	0.70	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	23.23	19.17	11.53	1.14	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	47.27	40.81	34.36	1.25	0.21	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.41	23.58	13.62	0.00	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	35.45	27.02	21.09	1.32	0.26	1.19
Fibroblast - Gingival, donor3	11394-118C8	39.35	41.87	28.43	1.26	0.39	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	94.54	85.19	75.84	5.19	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	59.20	41.76	38.76	1.59	1.41	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	56.75	33.36	19.33	1.71	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	42.46	25.29	17.99	1.76	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.70	20.47	21.17	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.26	29.54	22.67	1.61	0.44	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	29.45	18.00	14.45	1.09	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	52.76	31.37	24.90	1.86	0.55	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	75.57	50.48	47.98	3.37	2.05	0.29
Fibroblast - Lung, donor1	11270-116H1	10.87	6.80	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	25.37	17.91	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	22.79	25.75	19.42	0.84	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	5.83	4.17	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	13.99	4.20	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.76	3.92	3.36	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	18.67	15.43	13.40	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	7.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	35.74	29.78	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.47	28.51	21.14	1.16	0.78	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	30.34	29.12	20.93	0.61	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	62.42	32.13	28.46	0.31	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.54	31.67	17.94	1.14	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.09	32.13	20.25	1.89	1.08	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	80.02	58.68	62.28	1.51	1.16	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	37.03	20.12	19.12	0.88	0.66	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.44	13.61	10.57	0.61	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	6.68	6.01	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.30	20.16	15.02	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.37	18.85	12.30	1.19	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.43	32.50	19.18	2.31	0.18	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.07	16.36	11.63	0.99	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.66	32.19	21.36	3.31	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.78	15.33	10.26	0.22	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.47	12.40	9.62	0.25	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	27.24	25.10	15.59	1.97	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	48.32	40.70	21.45	2.61	0.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	13.36	10.65	6.33	0.90	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.76	10.58	8.46	0.00	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.39	18.56	14.00	0.83	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.45	23.59	18.29	1.20	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	43.02	29.56	13.47	1.97	1.31	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.20	19.07	10.44	0.64	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	24.96	17.88	13.83	0.34	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.74	8.63	7.84	0.31	0.16	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	3.49	7.84	4.36	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	47.33	18.72	22.88	0.69	0.00	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	31.49	18.74	17.44	0.78	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.58	21.72	15.59	0.51	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	5.36	19.14	1.53	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	9.57	1.91	3.19	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	14.55	14.55	11.13	1.71	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	7.17	23.16	7.72	3.03	0.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	5.25	13.01	6.85	1.83	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.30	17.44	7.93	2.58	0.99	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.29	25.11	8.46	2.11	0.79	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	6.52	13.05	5.54	1.96	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	16.80	14.15	4.86	3.10	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	11.02	20.63	6.22	2.40	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	16.75	18.72	7.14	2.59	0.62	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.40	9.67	6.18	1.61	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.12	17.47	9.79	0.87	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.08	18.96	12.60	0.83	0.83	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.45	10.78	10.57	1.22	0.20	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.07	14.38	9.36	1.60	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.38	14.33	13.83	0.50	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	32.57	15.96	7.21	1.09	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.78	18.91	12.41	1.18	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.00	13.99	11.13	0.95	0.48	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.62	16.09	11.39	0.89	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	21.78	13.31	6.45	0.81	0.60	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.92	16.12	9.84	1.19	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	40.88	14.81	16.49	1.06	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.60	16.13	11.97	1.25	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.15	15.20	8.54	1.02	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	21.36	17.82	10.62	0.89	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.53	16.97	12.73	1.66	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.26	15.52	10.82	2.65	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.42	17.12	10.93	1.86	1.03	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.22	18.91	11.07	2.31	0.81	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.68	15.84	9.34	1.67	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.18	18.08	8.38	1.10	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	26.57	21.03	13.16	1.84	1.35	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.80	10.86	7.94	0.32	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	19.88	9.30	0.64	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.45	16.01	11.09	1.42	0.09	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.21	14.87	12.50	0.47	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.10	13.99	9.12	0.91	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	32.51	16.73	14.43	0.94	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.71	18.00	13.39	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.21	14.87	15.71	1.12	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	36.39	11.94	14.91	1.11	0.65	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.56	13.64	10.70	0.80	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.96	13.92	11.48	0.61	0.15	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	37.31	13.34	11.66	0.52	0.78	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.70	19.79	13.55	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.10	14.56	8.66	0.92	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.05	17.55	11.84	0.66	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	15.87	11.90	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.73	14.38	9.10	0.66	0.92	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.78	14.73	15.13	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	13.47	16.27	16.27	1.27	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.94	16.92	5.18	2.19	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.40	20.49	10.17	2.00	0.92	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	12.07	20.66	6.55	3.27	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.07	12.20	4.38	2.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.52	10.74	3.67	1.70	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.07	6.00	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	9.90	12.37	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.83	10.06	4.64	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	12.84	1.60	4.81	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	13.91	19.13	3.48	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.51	10.09	3.91	1.30	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	8.24	9.47	4.53	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	10.00	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.39	11.75	0.84	0.28	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.82	10.13	4.58	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.03	10.90	0.00	3.36	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	7.00	9.54	1.27	1.27	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.45	6.45	2.04	0.34	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	20.88	6.26	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2.86	14.89	3.44	1.72	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.92	10.36	2.96	1.78	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	3.39	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	5.38	8.70	2.07	0.83	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	5.75	7.36	3.22	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	0.00	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	8.84	3.84	1.15	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	6.52	8.80	3.59	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	2.01	15.38	5.35	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	3.08	14.25	2.31	1.54	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	7.87	11.98	3.77	1.03	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	9.94	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2.83	11.80	2.36	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	5.43	12.67	3.62	3.02	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	3.56	18.31	1.02	3.56	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	5.58	15.95	3.99	2.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	5.43	14.80	1.48	1.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	7.08	20.07	2.36	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.83	16.92	5.25	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	4.39	17.99	4.83	2.19	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	4.24	12.72	1.70	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	5.37	9.55	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1.94	6.31	1.46	0.97	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	6.85	6.85	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	14.14	5.41	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	15.74	5.62	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	10.78	17.44	9.83	0.63	1.27	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.20	19.63	10.03	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	15.55	19.50	11.60	2.32	0.46	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	16.20	25.15	13.17	1.52	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.84	24.34	11.15	1.14	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.82	21.75	13.77	0.98	0.33	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	14.18	24.29	9.46	1.07	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.93	21.10	13.35	1.51	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.44	24.66	13.45	1.74	0.50	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.07	18.18	12.35	1.03	0.51	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	15.06	21.79	11.21	1.60	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	30.22	8.39	3.36	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	2.60	3.03	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	0.00	5.29	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	7.76	3.53	0.71	0.71	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1.45	5.81	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.76	12.41	8.57	0.70	0.00	0.52
Hepatocyte, donor1	11523-119I2	26.63	24.21	9.68	4.84	1.21	1.21
Hepatocyte, donor2	11603-120I1	19.39	20.47	7.54	5.39	0.00	0.00
Hepatocyte, donor3	11684-122I1	27.61	24.54	9.20	2.45	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	1.96	4.57	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.99	34.78	24.47	2.62	0.35	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.75	25.93	19.62	1.92	0.82	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	25.47	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	0.00	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	15.23	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	5.01	2.50	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	17.94	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	4.57	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	16.24	9.75	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	6.67	6.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	14.52	7.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	17.21	10.59	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	8.87	3.33	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	15.71	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	17.01	5.67	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	10.83	6.19	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	29.27	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	13.57	10.34	0.65	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	14.49	6.44	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	13.04	5.70	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	16.37	9.24	9.24	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	24.91	10.45	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	7.39	4.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	30.16	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.61	11.33	4.72	1.42	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	8.16	9.98	2.72	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	29.48	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	10.76	8.61	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	8.89	11.43	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	12.75	9.57	6.38	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	5.47	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	6.43	7.14	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	9.95	3.32	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.64	10.80	5.86	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	12.29	7.02	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	12.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.26	11.82	6.95	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	11.07	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	9.73	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	7.85	6.10	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	9.00	9.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	18.14	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	9.70	4.16	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	11.40	2.85	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	14.73	2.76	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	9.52	3.17	2.11	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.28	8.89	5.63	0.57	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	4.10	8.78	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.93	17.98	12.68	0.66	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	10.56	24.86	16.69	0.45	0.91	0.57
Keratocytes, donor1	11527-119I6	37.82	18.22	20.29	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	17.58	5.86	4.69	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	41.89	26.08	20.75	0.59	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	24.18	10.99	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	17.26	8.63	0.00	1.08	2.16
Lens Epithelial Cells, donor2	11609-120I7	24.80	36.10	18.68	1.61	0.69	0.00
Lens Epithelial Cells, donor3	11690-122I7	28.15	24.62	12.41	1.31	0.61	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.32	7.00	13.40	0.36	0.59	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	33.21	6.42	6.42	0.56	0.00	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.72	9.60	11.33	0.31	0.00	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	25.27	8.07	4.84	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.10	5.99	9.14	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.25	4.20	6.25	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	31.19	4.92	9.85	1.23	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	17.95	4.05	4.80	0.51	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.02	5.35	8.16	0.28	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.27	8.31	11.47	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	32.18	7.37	9.31	0.19	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	14.44	4.44	4.26	0.19	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	28.92	6.97	7.32	0.00	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.67	7.16	7.87	0.24	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.09	4.40	6.46	0.00	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	30.18	8.62	9.55	0.00	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.59	4.05	6.55	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.20	5.12	4.57	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.05	6.58	7.57	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.72	3.81	7.32	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.94	2.74	3.98	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	10.67	10.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.32	6.46	9.69	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.10	6.51	6.21	0.30	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	28.51	6.22	5.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.34	9.42	7.96	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.45	7.07	7.07	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.20	6.88	11.69	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	28.97	7.71	12.42	0.38	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.96	4.56	6.26	0.00	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	5.33	10.18	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.82	6.62	6.62	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.83	3.35	3.72	0.12	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.06	7.40	11.48	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	28.41	5.68	10.38	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.42	3.57	6.05	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.20	5.47	9.97	0.96	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.17	9.13	9.13	0.91	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.03	5.74	9.94	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	32.36	7.82	10.67	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	16.97	3.88	4.85	0.48	0.48	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.98	2.96	4.05	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.74	9.31	10.03	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.40	7.84	10.45	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.24	4.00	2.12	0.47	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.15	8.29	10.77	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	17.93	4.10	4.35	0.26	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	18.20	3.58	3.28	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	15.86	11.33	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.21	8.44	7.67	2.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	8.16	6.68	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.19	9.73	5.08	2.54	0.00	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	6.33	4.22	3.52	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	10.27	4.67	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	11.34	5.67	1.55	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	7.14	3.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.05	17.42	8.60	1.13	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.51	13.09	4.65	3.20	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.60	15.31	6.75	4.50	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.43	17.88	9.21	2.85	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.24	11.30	8.22	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.35	15.53	7.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	7.33	4.66	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	9.17	13.24	6.11	1.02	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.67	14.67	6.94	1.60	1.33	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.85	15.30	6.42	1.32	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.98	11.66	4.29	1.23	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	15.49	4.89	0.82	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.62	15.83	8.12	2.92	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.57	15.41	6.45	0.56	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	17.52	9.27	3.09	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.81	18.00	6.10	2.32	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	12.56	15.84	4.48	2.39	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	15.49	6.09	1.11	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	9.90	12.02	7.07	1.41	0.71	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.06	17.33	5.90	1.11	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	5.76	2.30	2.30	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	10.36	11.90	4.99	1.54	0.38	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	10.76	3.96	1.70	0.00	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	13.95	4.92	4.10	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	12.65	5.87	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	13.64	4.31	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	14.94	5.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.40	13.38	2.97	1.86	0.37	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	13.78	2.58	0.43	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	12.84	3.43	2.57	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.00	11.66	5.66	0.67	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	12.67	4.22	1.21	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	17.06	6.40	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.31	14.78	4.47	1.03	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	10.73	8.59	2.68	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	8.08	6.73	2.02	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.22	15.19	6.30	2.59	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	12.79	8.14	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	17.98	5.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.00	16.81	6.80	2.80	0.00	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	11.63	3.63	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	13.03	6.13	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.83	12.83	3.45	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	8.47	3.76	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.06	12.07	6.03	1.01	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	11.27	13.07	5.41	2.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	12.05	10.33	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.36	12.47	6.68	1.34	1.34	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.12	12.12	6.26	1.56	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.88	9.24	5.28	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	16.61	5.19	3.11	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	10.94	10.94	6.56	1.31	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	13.42	15.10	5.03	2.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.11	13.25	5.74	2.21	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.13	15.81	6.56	1.54	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.66	9.11	7.09	1.01	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	16.82	6.25	1.44	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.90	17.49	7.16	0.40	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	8.51	6.08	1.82	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.14	6.92	2.08	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.52	12.92	7.98	1.14	0.00	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.39	9.81	5.16	1.55	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	9.67	9.67	4.84	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.99	15.85	7.61	1.27	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.66	9.06	4.80	2.67	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	13.22	2.30	2.87	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	14.40	6.17	1.54	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	11.32	9.20	4.24	2.12	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.65	7.94	2.84	1.70	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.82	11.65	5.82	0.83	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	13.31	10.96	6.26	3.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	8.77	5.43	2.09	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.08	14.40	8.36	1.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.03	8.70	3.35	0.67	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	15.50	3.21	2.14	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	12.12	3.64	1.62	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	6.42	7.34	1.84	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	9.78	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.41	9.69	7.41	3.99	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	13.04	3.83	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	10.94	12.04	6.02	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.70	12.47	3.56	2.23	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.12	13.52	9.36	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	9.95	3.32	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	14.55	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	347.80	77.26	124.21	4.56	1.37	1.60
Macrophage - monocyte derived, donor2	11313-117C8	229.57	64.23	90.47	3.30	2.57	1.47
Macrophage - monocyte derived, donor3	11389-118C3	204.36	68.03	100.01	3.15	2.10	1.97
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	44.61	12.74	12.74	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	26.30	10.46	10.77	0.48	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	26.27	7.51	8.90	0.69	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	17.94	16.34	10.76	0.60	0.30	0.10
Mammary Epithelial Cell, donor2	11350-117G9	22.30	18.53	15.64	1.16	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	13.22	10.23	12.47	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	56.95	14.24	14.24	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	36.23	17.84	16.76	1.62	0.54	0.11
Mast cell, donor2	11565-120D8	44.28	18.72	22.29	1.19	0.30	0.30
Mast cell, donor3	11566-120D9	61.91	29.04	19.81	0.45	0.45	0.00
Mast cell, donor4	11567-120E1	43.79	21.45	20.21	0.71	0.89	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	39.26	14.42	13.42	0.44	0.89	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	25.68	5.84	4.09	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	49.22	16.86	17.44	1.03	1.03	0.23
Mast cell, expanded, donor8	11941-126A6	44.18	11.38	14.39	0.50	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	49.95	12.34	12.93	0.80	0.80	0.10
Melanocyte - dark, donor2	11582-120F7	23.88	16.96	10.73	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	71.93	24.77	34.34	1.52	0.65	0.22
Melanocyte - light, donor1	11274-116H5	24.45	10.81	14.57	0.71	0.47	0.00
Melanocyte - light, donor2	11351-117H1	18.43	7.51	12.28	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	24.28	9.54	12.14	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	61.23	22.80	24.37	0.73	1.46	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	103.54	25.82	32.81	2.42	0.27	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	46.34	20.36	20.62	1.34	0.80	0.27
Meningeal Cells, donor1	11493-119E8	27.54	15.76	14.27	0.50	0.37	0.00
Meningeal Cells, donor2	11573-120E7	28.61	21.57	14.52	1.32	1.32	0.00
Meningeal Cells, donor3	11654-122E7	49.55	19.89	22.33	0.98	0.33	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	25.66	22.53	15.97	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	60.68	33.81	39.45	2.31	0.60	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	6.54	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	34.45	17.22	10.05	0.72	0.00	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	41.29	31.98	19.27	1.69	0.42	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	41.22	24.13	25.63	1.01	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.99	9.01	6.81	0.88	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	5.11	2.19	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.16	9.62	5.12	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.22	24.10	18.84	1.11	0.69	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	12.27	5.95	1.49	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.97	25.00	21.71	1.58	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	10.68	5.04	1.19	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	4.67	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.89	4.48	5.76	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	45.72	24.81	28.71	1.06	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.95	31.59	22.20	1.25	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.24	16.69	13.06	3.63	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	68.42	67.35	63.64	3.18	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	40.54	47.54	33.03	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	20.60	26.95	17.56	0.79	0.43	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	148.54	21.61	72.92	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	173.62	45.07	49.99	2.22	2.22	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	189.04	70.67	80.09	5.89	1.47	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	297.31	62.23	72.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	158.07	43.39	49.90	1.55	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	186.48	50.20	56.84	4.36	1.04	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	199.18	44.00	34.74	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	163.67	44.05	56.56	2.50	1.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	192.71	49.81	64.24	4.65	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	19.47	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	159.73	34.95	43.49	2.24	1.22	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	208.28	52.66	78.40	3.56	1.58	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	34.21	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	127.43	21.24	28.32	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	189.97	58.13	73.33	4.94	2.28	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	257.92	23.69	80.27	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	134.34	29.50	36.71	2.55	1.06	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	151.94	40.52	53.41	1.84	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	117.73	27.72	33.08	2.09	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	149.22	28.50	53.65	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	0.00	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	140.51	29.36	33.37	1.25	1.51	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	165.89	41.59	52.29	4.75	0.71	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	177.48	21.56	43.12	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	120.65	30.39	36.61	1.84	1.38	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	162.59	51.53	71.30	2.94	2.10	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	111.49	27.31	32.61	2.04	1.22	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	131.51	33.04	35.18	3.00	1.29	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	151.16	38.23	50.02	3.11	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	185.73	10.32	30.96	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	99.65	27.82	34.82	1.75	1.75	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	134.34	37.01	41.57	2.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	137.53	28.17	62.97	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	99.20	20.11	34.52	1.63	1.36	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	148.22	36.17	55.29	4.12	1.76	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	83.95	25.08	20.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	114.85	31.72	34.60	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	166.50	42.02	56.43	2.40	1.60	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	68.56	17.83	10.97	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	110.13	21.02	30.03	1.50	1.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	10.19	16.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	108.60	26.71	28.03	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	105.95	30.90	37.52	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	67.24	17.29	23.05	0.64	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	97.43	24.30	30.49	1.49	1.49	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	111.34	34.79	46.63	2.09	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	17.68	13.26	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	114.19	28.03	31.79	1.71	1.03	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	95.40	28.88	36.76	1.31	3.06	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	52.91	12.43	17.75	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	74.63	21.60	26.65	1.40	1.12	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	166.67	37.82	49.46	0.83	1.66	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	52.45	8.74	16.32	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	65.76	10.56	19.91	1.81	1.21	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	173.63	46.33	55.10	2.50	2.50	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	36.09	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	65.57	13.85	23.09	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	116.10	34.15	34.72	2.28	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	48.09	12.16	18.93	0.41	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	60.12	13.73	25.91	0.26	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	119.68	36.89	44.18	1.29	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	56.53	10.80	18.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	56.85	15.21	24.02	1.07	0.53	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	200.55	52.08	65.85	3.89	1.80	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	50.29	13.28	18.79	0.14	0.99	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	59.24	15.93	18.16	0.96	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	139.31	39.80	47.54	2.65	1.77	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	65.22	12.89	18.96	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	65.34	18.75	15.63	1.42	1.70	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	149.94	46.46	47.19	1.97	1.23	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	87.98	18.25	44.31	1.30	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	86.44	20.58	33.81	1.76	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	173.00	51.03	62.28	5.48	2.59	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	178.46	24.32	43.69	2.06	1.24	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	147.70	33.65	46.45	3.28	0.30	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	380.45	45.20	109.24	3.77	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	279.81	51.69	80.20	5.35	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	259.57	39.76	64.73	1.64	0.99	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	260.88	44.18	58.91	1.05	1.05	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	610.26	108.93	156.77	7.51	5.93	2.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	433.06	66.12	88.48	4.66	3.73	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	261.74	56.33	81.49	7.51	0.75	4.51
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	259.95	62.59	86.03	5.59	1.33	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	350.05	51.91	96.59	3.05	2.04	1.92
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	170.18	45.68	44.20	2.21	2.21	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	221.69	44.34	66.69	2.56	2.93	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	206.89	46.67	71.56	3.11	3.11	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	359.68	59.32	87.65	5.34	2.14	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	139.10	38.64	46.37	7.73	0.00	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	216.13	49.49	40.40	4.04	2.02	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	204.92	44.69	74.21	3.37	1.69	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	344.57	46.31	113.04	5.45	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	284.20	35.60	79.47	3.18	2.54	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	384.67	42.11	71.27	7.29	0.81	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	137.45	36.25	66.46	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	28.55	34.26	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	143.55	16.31	55.46	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	180.59	14.26	47.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	37.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	36.41	20.90	15.94	1.72	0.22	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.16	15.68	9.93	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.70	21.36	16.69	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	25.04	19.62	18.36	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.24	15.59	12.17	0.57	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	23.94	3.19	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	16.32	10.88	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	12.86	14.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	26.37	26.79	22.18	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	42.07	21.85	20.92	0.93	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	19.73	16.75	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.35	16.82	9.88	1.47	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	17.37	22.34	18.37	1.49	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	32.48	23.82	23.82	2.17	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	30.60	32.42	24.94	2.49	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.09	21.23	18.45	0.49	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.42	22.24	16.77	2.00	1.28	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	25.99	20.69	2.65	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.01	21.61	19.21	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.33	14.11	20.35	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	34.80	24.07	23.91	2.11	0.98	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.04	18.70	20.99	1.76	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	27.43	32.35	18.28	2.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.42	32.18	31.72	2.76	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	32.46	26.03	26.35	0.96	0.96	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.25	17.59	14.49	0.69	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	17.70	5.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.83	19.83	15.82	1.34	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	34.29	16.94	19.05	1.69	1.27	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	31.09	20.65	32.28	2.14	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	24.90	26.61	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	28.32	21.66	17.66	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	12.17	8.12	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	11.90	12.30	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	24.14	15.79	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.84	17.41	21.19	1.51	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	12.38	12.06	0.98	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	23.53	18.30	18.30	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	8.59	8.59	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	20.28	11.46	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	29.92	25.26	20.61	1.99	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	35.22	19.35	24.31	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	14.16	9.57	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	58.07	43.25	52.63	2.42	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.82	11.94	8.62	0.88	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	8.81	9.49	2.71	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	10.22	30.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	40.24	23.78	1.83	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	14.16	11.65	1.26	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	24.82	22.09	21.19	1.51	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	17.41	15.82	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	20.41	6.80	11.34	4.53	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	10.12	20.23	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.33	23.73	18.39	1.86	0.37	0.37
Myoblast, donor2	11322-117D8	29.15	29.34	23.97	1.73	1.15	1.53
Myoblast, donor3	11398-118D3	18.50	15.13	9.92	1.01	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	26.71	22.77	16.34	1.02	0.58	0.00
Natural Killer Cells, donor1	11230-116C6	15.07	15.07	9.23	0.62	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	7.84	14.47	8.14	0.60	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	16.56	13.07	7.55	0.00	0.18	0.55
Neural stem cells, donor1	11275-116H6	18.51	12.70	10.16	1.45	0.00	0.00
Neural stem cells, donor2	11352-117H2	7.70	5.78	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	3.41	5.69	4.55	0.00	0.00	1.14
Neurons, donor2	11574-120E8	12.55	14.31	10.35	1.10	0.22	0.00
Neurons, donor3	11655-122E8	9.04	6.58	0.82	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	24.13	15.78	19.49	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	20.29	11.60	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	45.20	18.33	23.21	0.61	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	10.57	25.17	12.94	1.07	0.47	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	10.74	19.54	8.14	0.98	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	15.44	20.66	12.43	1.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	7.85	8.12	6.74	0.41	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	11.43	13.46	8.54	0.29	0.00	1.45
Olfactory epithelial cells, donor3	11935-125I9	16.80	14.98	9.42	1.36	0.57	0.45
Olfactory epithelial cells, donor4	11936-126A1	11.30	14.90	9.74	0.97	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	17.45	19.86	8.43	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	14.89	19.78	15.10	1.49	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	36.58	16.00	27.43	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	27.31	16.14	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	6.25	4.69	4.89	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	13.34	16.15	7.73	2.11	1.40	0.00
Osteoblast, donor3	11426-118G4	17.24	15.82	12.26	0.53	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	42.03	30.75	32.51	1.68	1.18	0.67
Pericytes, donor1	11491-119E6	3.34	6.56	4.34	1.45	0.33	0.00
Pericytes, donor2	11571-120E5	2.49	6.79	2.26	0.68	0.45	0.00
Pericytes, donor3	11652-122E5	6.51	9.56	6.31	0.61	0.20	0.00
Perineurial Cells, donor1	11499-119F5	27.69	26.67	20.12	0.90	1.02	0.11
Perineurial Cells, donor2	11579-120F4	35.06	22.63	17.30	0.92	0.55	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	49.40	10.52	19.44	0.64	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	31.59	11.75	10.77	0.73	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	29.38	16.95	11.91	0.39	0.91	0.52
Placental Epithelial Cells, donor1	11278-116H9	5.98	5.26	5.26	0.24	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	5.54	5.54	4.44	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.73	7.26	2.94	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	24.05	21.20	21.20	1.27	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	20.07	13.69	13.32	1.88	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	38.24	19.97	17.49	1.31	0.39	0.26
Preadipocyte - breast, donor2	11328-117E5	27.24	21.39	17.56	1.58	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	49.76	37.93	33.67	3.41	0.32	0.32
Preadipocyte - omental, donor2	11329-117E6	40.16	21.82	24.01	3.49	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	23.06	21.92	22.78	0.86	0.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	12.80	18.70	15.75	1.97	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	11.67	15.66	9.21	0.31	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	23.20	21.78	14.34	1.06	0.18	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	34.06	39.51	23.33	1.70	1.36	1.02
Preadipocyte - visceral, donor1	11280-116I2	34.74	27.29	19.84	1.02	0.65	0.28
Preadipocyte - visceral, donor2	11357-117H7	51.54	25.31	21.63	0.92	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	18.60	16.30	13.58	0.84	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.53	27.61	15.09	2.26	0.60	0.00
Prostate Epithelial Cells, donor2	11331-117E8	20.18	13.27	11.78	1.22	0.00	0.41
Prostate Epithelial Cells, donor3	11404-118D9	12.49	15.43	12.92	0.61	0.12	0.67
Prostate Stromal Cells, donor1	11254-116F3	50.69	34.74	27.11	2.39	0.91	0.46
Prostate Stromal Cells, donor2	11332-117E9	57.91	35.86	29.23	2.15	0.18	1.79
Prostate Stromal Cells, donor3	11405-118E1	47.65	43.59	35.66	2.50	0.73	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	6.20	3.65	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.05	16.29	14.35	0.83	0.21	0.28
Renal Epithelial Cells, donor1	11517-119H5	4.06	7.61	4.57	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	7.11	4.27	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.95	22.87	10.69	0.74	0.74	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	2.72	6.13	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	24.53	7.28	7.82	0.27	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	7.99	6.44	0.22	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	8.65	0.67	2.66	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.74	6.82	4.40	0.88	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.64	9.40	8.15	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.66	4.99	1.39	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.25	18.25	7.78	0.81	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	10.54	5.90	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	8.87	6.94	3.66	0.00	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	45.37	38.37	26.19	1.81	1.04	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.36	12.79	10.80	1.99	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	3.09	6.17	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.58	16.56	7.28	1.76	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	102.36	62.68	47.71	6.15	1.60	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	53.60	50.03	39.31	2.68	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.66	17.06	10.46	3.30	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.30	22.04	20.88	2.32	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.45	23.53	15.86	2.47	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.75	30.88	17.78	2.38	0.30	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	39.71	43.50	28.78	3.57	0.67	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	30.02	15.63	1.86	1.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	23.08	32.52	21.44	2.45	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.50	31.43	21.03	2.54	0.92	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.80	20.40	13.01	2.19	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.46	28.14	15.73	2.87	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	41.21	45.69	29.57	2.87	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.95	24.53	12.62	2.87	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	21.14	27.58	17.49	2.04	0.75	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.69	34.52	21.91	2.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	22.18	19.12	11.85	2.10	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.66	28.23	17.24	1.12	0.93	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	38.15	30.44	26.87	2.82	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.17	18.98	13.14	1.59	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.64	27.26	16.84	1.95	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	22.15	29.03	21.20	3.25	1.34	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.07	21.15	13.56	2.03	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.27	20.74	15.98	1.12	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.44	26.15	14.87	1.71	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	18.96	18.78	10.94	1.82	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.54	27.96	19.50	1.96	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.13	32.64	20.28	2.42	0.67	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.52	21.70	11.79	1.65	1.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.02	33.14	13.69	2.18	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.13	30.17	17.77	2.10	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.19	24.68	16.38	3.32	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.46	21.24	13.72	1.33	0.88	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	23.40	35.93	16.71	1.88	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	23.42	22.34	12.52	2.02	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.41	24.35	12.77	1.19	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.75	33.16	18.51	1.35	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.29	22.18	11.18	3.61	1.03	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.59	29.63	18.93	1.92	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.85	27.09	15.76	1.64	0.66	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.55	20.62	11.76	1.87	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.00	30.33	18.05	3.26	1.48	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.72	22.92	11.20	1.87	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.86	32.49	18.94	4.29	0.97	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.00	44.29	24.76	4.29	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	25.39	31.24	19.35	1.41	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	32.77	38.33	18.46	5.27	0.85	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	41.92	41.92	24.80	5.24	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.31	45.63	28.11	3.02	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	37.21	37.21	23.25	4.16	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	70.01	65.79	42.79	7.28	1.02	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	76.05	70.58	36.51	4.26	0.61	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	38.28	33.76	19.29	4.22	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	65.82	74.87	53.38	6.33	2.04	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	59.31	69.49	38.34	3.59	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	67.42	61.04	41.44	6.02	2.13	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	66.81	73.21	58.91	5.34	2.56	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	60.70	53.49	33.65	4.81	0.60	1.20
Schwann Cells, donor1	11498-119F4	4.14	4.51	2.63	0.00	0.56	0.00
Schwann Cells, donor2	11578-120F3	17.01	17.01	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.85	17.53	11.61	0.88	0.66	0.66
Sebocyte, donor1	11220-116B5	15.89	13.69	10.41	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	11.49	10.57	7.35	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	8.45	9.28	9.48	0.21	0.21	0.00
Sertoli Cells, donor1	11255-116F4	38.10	23.19	23.19	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	28.24	8.47	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	6.42	8.62	5.37	0.00	0.09	0.09
Skeletal Muscle Cells, donor2	11358-117H8	10.12	7.95	7.95	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	10.87	5.02	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	23.72	18.22	14.30	1.41	0.94	0.16
Skeletal Muscle Cells, donor5	11455-119A6	15.76	17.99	9.81	0.74	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	13.54	19.39	10.00	0.77	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	21.67	24.45	20.67	1.01	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.70	21.26	12.70	0.43	0.14	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	21.73	23.31	15.28	0.79	0.50	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.16	8.59	6.15	0.59	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	8.69	4.34	4.34	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.02	6.19	3.44	0.14	0.28	0.28
Skin - palm, donor1	10286-104F7	34.92	24.17	10.74	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.59	7.06	10.67	0.29	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	16.36	9.00	9.81	0.00	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.19	6.23	5.32	0.13	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	24.60	11.82	14.60	0.42	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	14.63	8.02	7.45	0.28	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	39.96	17.55	17.97	0.63	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	15.44	12.82	12.29	0.30	0.45	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.85	4.01	1.23	0.00	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	119.39	82.48	53.58	7.34	1.33	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	32.33	30.57	14.70	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.10	9.28	12.38	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	11.81	6.30	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.04	24.72	27.81	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	25.02	16.01	8.01	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.78	11.18	8.38	0.40	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.07	27.71	18.18	1.33	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.14	8.58	4.99	0.26	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	36.79	36.47	29.63	2.28	0.33	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.10	38.10	25.69	3.25	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.04	30.47	25.20	1.00	0.85	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.51	7.32	5.86	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.09	15.22	11.26	1.52	0.30	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.37	11.11	13.13	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	3.81	7.15	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.05	32.44	21.83	1.62	0.15	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.63	23.46	20.23	1.51	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.84	32.01	24.25	1.57	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.54	9.74	6.65	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	11.86	5.39	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.61	11.66	12.55	1.20	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.44	4.10	5.46	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	22.54	22.07	15.47	1.02	0.39	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.30	20.83	11.57	0.40	0.30	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	51.65	29.35	24.35	1.14	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.23	10.26	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.03	28.35	13.25	1.59	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	37.02	35.55	23.30	1.46	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.44	31.30	24.29	2.75	0.75	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	59.36	38.30	33.99	1.52	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.25	22.77	19.00	0.75	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	20.25	11.25	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	1.29	6.46	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.23	18.60	13.02	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.14	14.14	7.57	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.03	13.48	5.01	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.39	16.22	10.62	1.77	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.82	21.74	18.58	1.25	0.75	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.31	34.10	21.02	1.87	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	13.10	7.92	6.76	0.00	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	11.98	9.69	0.51	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	6.39	5.64	0.75	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.71	21.38	14.11	0.70	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	13.41	17.60	9.72	0.92	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	7.62	4.76	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.28	5.38	5.63	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.97	21.87	16.57	1.77	1.55	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.21	13.17	9.95	0.29	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	27.79	24.68	18.66	1.55	0.00	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.69	24.86	25.12	3.17	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	14.51	5.95	1.12	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	39.89	32.70	23.36	1.80	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.66	32.93	26.12	4.83	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.94	15.36	9.06	0.79	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.66	22.86	17.52	1.52	0.00	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	21.56	37.54	25.96	2.40	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	46.40	40.13	36.78	3.76	0.00	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	47.21	41.25	34.84	2.29	0.00	0.92
Synoviocyte, donor1	11291-117A4	12.29	14.64	7.91	1.68	0.17	0.34
Synoviocyte, donor2	11368-117I9	30.34	33.02	29.17	0.34	0.67	0.67
Synoviocyte, donor3	11440-118H9	9.38	17.87	16.53	0.89	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	19.30	12.86	9.29	0.71	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	5.95	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.11	5.79	5.33	0.46	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.96	11.25	6.45	0.43	0.36	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	5.80	5.03	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	5.15	2.86	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	99.28	66.19	51.79	4.55	1.60	0.37
Urethra, donor2	10319-105A4	7.19	10.79	12.59	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.19	4.25	4.78	0.00	0.53	0.00
Urothelial Cells, donor2	11600-120H7	4.81	3.20	2.80	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	4.81	7.33	2.06	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	18.28	19.84	17.16	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	16.02	19.58	0.89	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	22.87	11.44	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.80	10.27	13.01	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.63	10.67	9.30	0.69	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	20.92	8.13	6.97	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	11.45	7.29	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	28.45	13.77	10.10	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	6.39	8.22	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	116.82	59.58	58.72	5.06	1.23	0.86
Wilms' tumor cell line:HFWT	10597-108E3	22.00	47.52	29.04	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	7.82	18.16	8.66	0.56	0.28	0.00
achilles tendon, donor2	10292-104G4	10.33	0.00	10.33	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.14	10.96	4.33	2.04	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.02	15.32	8.13	1.39	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.77	11.16	6.41	1.07	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.61	20.68	9.52	3.27	1.09	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.30	12.37	5.90	0.84	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	55.41	25.17	26.86	3.17	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	32.94	12.79	11.16	0.27	0.82	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.74	15.86	9.69	0.44	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	18.38	15.11	6.13	1.23	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.18	26.02	19.41	1.16	0.78	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.36	4.23	2.94	0.74	0.55	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	7.80	7.80	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	11.85	8.13	4.18	0.23	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	11.13	11.39	8.28	0.52	1.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.95	19.29	12.57	0.29	0.00	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	34.39	24.63	18.13	0.46	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	50.58	27.14	30.84	0.82	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	21.49	25.48	12.89	0.92	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	32.86	36.70	25.18	1.71	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.93	53.99	42.46	2.43	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	38.27	35.87	28.64	3.85	1.44	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	33.19	15.15	14.48	1.34	0.89	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	7.67	12.67	8.34	1.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	3.72	22.30	3.72	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.88	5.27	2.64	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.87	1.74	1.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	9.37	13.12	3.75	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	43.80	51.57	44.74	1.88	1.88	0.00
adipose tissue, adult, pool1	10010-101C1	61.89	22.18	28.54	1.09	0.62	0.00
adipose, donor1	10184-103D4	5.86	14.07	7.04	2.35	0.00	0.59
adipose, donor2	10185-103D5	2.84	14.19	3.24	3.65	0.41	0.41
adipose, donor3	10186-103D6	5.72	11.98	5.45	1.09	0.27	0.00
adipose, donor4	10187-103D7	12.13	7.80	7.80	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	4.58	23.20	5.52	5.05	0.63	0.32
adrenal gland, adult, pool1	10081-102A9	3.64	18.19	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	8.27	22.81	8.14	1.33	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	44.66	29.30	1.07	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	300.25	43.36	77.21	3.48	2.09	1.39
amniotic membrane cells, donor2	12236-129G4	27.39	72.02	34.49	3.72	4.40	1.01
amniotic membrane cells, donor3	12237-129G5	2.06	16.79	4.12	0.59	0.29	0.59
amygdala - adult, donor10196	10167-103B5	3.56	17.79	2.37	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	4.06	10.34	5.27	1.82	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	6.46	5.81	4.52	0.97	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	29.03	22.28	20.88	0.64	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	15.00	18.53	9.93	0.22	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	4.68	24.38	5.34	2.00	0.67	0.00
aorta, adult, pool1	10052-101G7	17.65	25.89	13.73	0.39	0.39	0.39
appendix, adult	10189-103D9	11.26	19.02	12.42	0.39	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7.57	18.92	8.60	7.22	0.34	0.34
artery, adult	10190-103E1	13.59	12.23	6.79	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	58.82	49.11	41.72	1.74	2.17	0.29
b cell line:RPMI1788	10427-106D4	3.72	12.79	3.27	1.49	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.98	20.81	11.93	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.27	21.04	18.75	0.50	0.30	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	15.23	20.75	10.88	0.67	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	8.95	10.63	7.83	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	15.54	26.07	13.47	1.20	0.87	0.00
blood, adult, pool1	10053-101G8	17.72	6.64	15.50	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	73.65	33.40	30.83	1.71	2.57	0.00
bone marrow, adult	10192-103E3	52.64	26.32	29.02	2.02	0.67	0.00
brain, adult, donor1	10084-102B3	2.05	12.30	4.10	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	6.01	15.03	6.46	1.34	0.11	0.00
brain, fetal, pool1	10085-102B4	2.67	8.01	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	15.20	31.05	10.90	2.64	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	6.99	17.35	8.86	1.25	0.62	0.00
breast, adult, donor1	10080-102A8	17.68	18.31	13.89	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.02	20.33	14.48	0.64	0.89	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.13	11.75	8.66	0.93	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.30	8.98	2.76	0.46	0.00	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	6.54	14.28	5.08	0.00	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	3.76	29.15	10.34	3.76	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.39	14.22	13.02	1.64	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	3.49	16.16	2.54	0.95	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.11	31.41	9.85	4.26	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	6.91	20.72	10.36	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	5.52	17.07	6.02	1.34	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	6.11	18.34	6.88	3.82	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	11.35	12.09	4.03	1.83	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	8.74	17.48	5.83	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	4.70	12.38	4.27	2.35	0.00	0.00
cerebellum, adult, pool1	10083-102B2	2.41	17.59	2.76	3.10	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	2.49	6.64	1.66	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	6.81	13.36	8.57	2.27	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	7.31	8.77	2.92	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.93	24.87	17.54	1.44	1.58	0.00
cervical cancer cell line:ME-180	10553-107I4	28.34	24.19	15.91	0.83	0.83	0.00
cervix, adult, pool1	10013-101C4	23.62	34.54	16.90	2.62	0.31	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	157.87	97.54	113.42	5.02	3.62	2.37
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	28.74	23.51	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.61	33.55	14.04	1.49	0.62	0.50
choriocarcinoma cell line:SCH	10785-110H2	10.60	13.68	7.39	1.60	0.99	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	20.63	11.86	3.79	1.42	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	1400.38	134.77	317.97	11.40	7.12	19.09
chorionic membrane cells, donor2	12239-129G7	123.29	52.30	57.17	2.68	1.79	0.89
chorionic membrane cells, donor3	12240-129G8	1150.07	103.30	185.73	10.44	1.10	17.03
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	13.13	9.09	1.01	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	14.98	9.03	7.30	0.38	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.36	9.50	7.39	0.00	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	6.68	14.64	5.91	0.00	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.56	16.69	5.56	1.45	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	8.14	14.25	3.87	2.04	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	18.55	36.81	25.32	2.36	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.81	7.30	8.34	0.26	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.34	42.52	13.03	3.89	1.14	1.83
clear cell carcinoma cell line:TEN	10636-108I6	3.30	1.39	2.60	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	83.65	45.03	33.86	4.58	0.73	0.00
colon carcinoma cell line:COLO-320	10420-106C6	10.64	34.97	6.46	2.66	0.38	0.00
colon, adult, donor1	10082-102B1	16.66	40.46	7.14	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	37.13	34.08	25.26	2.00	1.53	0.00
colon, fetal, donor1	10070-101I7	19.16	26.57	13.60	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	32.08	36.67	32.08	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	13.60	7.65	4.25	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	17.96	11.62	5.89	0.45	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	18.90	14.10	9.02	1.13	0.71	0.42
corpus callosum, adult, pool1	10042-101F6	7.30	14.82	8.40	1.55	0.55	0.00
cruciate ligament, donor2	10295-104G7	22.69	13.78	6.48	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	4.01	13.64	4.01	0.00	1.61	0.00
diencephalon, adult	10193-103E4	3.12	8.16	2.40	1.20	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.81	10.56	2.76	0.46	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.54	17.18	12.57	2.05	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.50	44.05	28.16	5.30	0.72	0.72
ductus deferens, adult	10196-103E7	18.94	18.94	8.47	1.99	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	24.48	30.24	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	27.95	17.66	2.21	0.74	2.21
dura mater, adult, donor1	10041-101F5	42.53	36.17	25.27	1.73	1.24	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	37.53	8.88	8.44	1.33	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	25.36	22.50	11.89	2.44	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	11.72	9.87	8.63	2.47	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	6.96	24.82	16.35	2.72	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	13.89	18.83	15.13	1.54	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	22.33	14.45	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	17.09	35.53	13.41	4.36	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	12.32	31.53	13.96	2.90	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.56	19.94	10.45	2.41	0.64	1.13
epidermoid carcinoma cell line:A431	10426-106D3	19.90	16.90	14.67	0.78	0.67	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	34.54	16.83	20.35	0.55	0.22	0.11
epididymis, adult	10197-103E8	45.00	57.77	39.56	6.07	2.30	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	19.87	55.88	26.61	4.44	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	49.94	29.10	36.96	1.97	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.08	23.46	14.81	1.97	0.66	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.53	25.29	15.65	2.26	0.98	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.13	24.98	17.14	1.12	1.23	1.01
esophagus, adult, pool1	10015-101C6	13.59	21.24	11.04	1.49	0.42	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.34	105.45	58.49	19.16	2.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	12.07	12.07	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	6.31	10.52	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	1.49	10.42	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	10.32	19.49	10.32	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	14.57	11.66	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	10.93	26.44	10.68	2.54	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	30.39	17.95	18.21	0.38	0.38	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	18.52	15.67	12.58	0.24	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	6.00	16.98	6.76	2.81	0.47	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	19.52	18.62	16.21	0.60	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	40.96	56.05	50.66	3.20	1.37	0.09
gall bladder, adult	10198-103E9	24.63	28.01	17.14	1.45	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	8.05	23.08	12.35	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	14.94	19.80	13.07	1.87	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.01	16.69	11.62	2.32	1.48	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	19.53	29.01	10.44	1.35	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	100.67	74.76	45.58	9.84	2.62	0.49
gastric cancer cell line:GSS	10560-108A2	11.90	23.80	16.47	2.75	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	24.22	25.59	11.88	1.83	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	16.29	13.20	12.85	0.23	0.23	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	17.63	36.25	14.70	1.82	0.84	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.47	10.48	11.72	1.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.92	30.82	23.22	2.85	0.84	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.91	31.88	23.59	2.81	0.84	0.14
glioblastoma cell line:T98G	10485-107A8	26.71	27.48	17.99	1.66	0.99	0.22
glioma cell line:GI-1	10413-106B8	23.43	22.84	19.62	2.93	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	2.19	10.20	3.64	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	8.30	10.50	6.59	0.73	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	6.85	1.37	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	7.99	6.40	3.73	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	325.47	100.33	92.99	2.45	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	20.91	15.68	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	10.88	15.04	5.76	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	6.43	10.10	0.92	1.38	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	7.77	8.23	1.37	5.03	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	7.09	10.31	2.58	2.58	0.64	0.00
hIPS, biol_rep1	14380-156B6	4.31	2.87	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	7.54	15.09	2.74	3.43	0.00	0.00
hIPS, biol_rep3	14382-156B8	2.21	8.83	2.21	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.30	9.77	2.87	0.86	0.00	0.29
heart - mitral valve, adult	10205-103F7	11.66	16.74	11.06	0.60	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	7.84	17.00	9.94	1.05	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	16.65	16.65	12.49	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	13.47	21.83	13.67	3.47	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	24.70	22.99	16.61	2.55	0.85	0.43
heart, adult, pool1	10016-101C7	41.40	39.10	29.90	4.14	1.61	0.00
heart, fetal, pool1	10046-101G1	14.17	18.07	12.22	2.36	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.30	21.60	21.60	0.31	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	14.27	16.65	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.34	14.59	9.83	1.22	0.77	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	20.51	17.84	8.62	1.21	0.36	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.52	13.54	10.21	0.51	0.61	0.10
hepatoma cell line:Li-7	10484-107A7	72.62	49.27	42.93	2.67	2.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.55	15.88	5.03	1.31	1.01	0.00
hippocampus - adult, donor10196	10169-103B7	4.73	12.30	5.68	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	6.94	9.39	5.10	1.22	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	5.98	5.98	3.49	2.99	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	5.99	4.23	3.17	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.99	21.36	8.54	4.27	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.92	12.96	5.30	1.57	0.39	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	11.68	18.53	7.62	2.54	1.02	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.13	24.81	4.51	3.38	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.36	15.23	2.58	1.81	0.52	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.18	20.50	7.21	3.80	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.80	13.14	5.55	2.63	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.74	14.86	4.52	2.59	0.65	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.84	16.27	4.59	2.50	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	14.21	14.68	9.95	3.79	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5.95	11.41	6.11	1.13	0.16	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	9.43	9.43	13.47	1.35	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.17	15.18	5.63	1.88	0.63	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	8.84	11.79	4.42	2.95	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	7.85	5.24	2.62	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.73	18.33	5.35	2.48	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.85	19.62	3.05	3.05	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	3.50	14.49	5.50	1.00	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2.64	15.82	3.58	1.32	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	2.27	19.55	2.27	0.91	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	3.13	17.23	3.13	2.51	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.35	14.04	6.53	2.12	0.00	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.39	9.29	6.39	2.03	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	5.08	19.13	6.58	1.49	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.42	11.27	4.25	1.85	0.18	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.84	17.97	5.14	3.14	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.76	14.29	7.35	4.08	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	5.28	14.79	4.22	2.11	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.02	19.32	4.43	0.63	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.36	22.70	7.26	3.33	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	5.17	20.68	2.07	3.62	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	6.64	15.28	3.32	3.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.39	13.08	7.18	1.54	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.99	13.29	6.90	2.30	1.53	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	11.36	12.87	7.57	3.79	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	13.78	20.50	12.77	1.01	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.90	14.73	2.90	2.90	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.13	15.60	5.79	2.23	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	9.76	19.51	5.85	2.44	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	3.67	20.17	4.28	3.06	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	16.27	3.25	3.25	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	3.64	12.58	3.31	3.64	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.11	14.23	3.83	3.83	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	3.98	16.65	4.34	3.26	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	18.86	3.91	4.27	0.36	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	5.97	8.35	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.62	15.71	5.42	2.84	0.54	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.47	11.85	6.20	2.42	0.27	0.27
immature langerhans cells, donor1	11904-125F5	25.18	16.47	14.77	1.70	0.73	0.24
immature langerhans cells, donor2	11905-125F6	18.22	12.67	18.22	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	6.25	17.32	5.68	3.12	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	21.78	22.76	15.61	2.28	0.00	0.00
kidney, adult, pool1	10017-101C8	36.15	24.53	16.92	1.50	0.70	0.20
kidney, fetal, pool1	10045-101F9	24.90	28.58	14.93	3.54	0.35	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	7.10	10.08	6.53	0.14	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.36	63.73	30.97	5.39	1.94	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.22	18.35	15.78	0.92	0.55	0.18
left atrium, adult, donor1	10079-102A7	21.25	25.06	12.53	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	20.73	21.24	13.15	3.03	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	2.46	10.67	3.28	1.37	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	30.18	38.44	17.60	2.51	0.72	2.87
leiomyoma cell line:15242A	10570-108B3	33.15	34.78	24.46	1.63	1.09	1.09
leiomyoma cell line:15425	10571-108B4	26.47	34.48	18.21	1.70	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	12.55	9.41	2.09	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	27.15	13.69	17.35	0.59	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	44.83	44.21	33.12	2.34	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	43.37	38.74	31.56	2.19	1.34	0.00
liver, adult, pool1	10018-101C9	32.57	35.49	16.69	4.05	0.65	0.00
liver, fetal, pool1	10086-102B5	9.41	17.87	7.53	3.76	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	3.50	6.71	2.19	0.58	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	8.12	7.01	4.43	0.92	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	7.62	10.44	4.80	1.69	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	8.83	3.79	3.36	0.42	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	14.67	28.79	10.52	2.77	1.38	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	10.34	17.92	11.72	0.69	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.84	23.60	13.18	1.85	0.79	0.13
lung, adult, pool1	10019-101D1	60.95	32.13	31.66	1.54	1.30	0.35
lung, fetal, donor1	10068-101I5	11.70	10.85	6.85	1.14	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	65.07	21.54	27.95	1.83	0.00	0.00
lymph node, adult, donor1	10077-102A5	20.35	8.52	8.05	0.00	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	20.60	35.07	14.47	3.07	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3.92	4.68	2.26	1.06	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	5.10	9.34	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	16.43	28.42	11.54	2.66	0.89	0.00
mature adipocyte, donor2	12232-129F9	27.60	20.55	12.04	2.08	1.45	0.00
mature adipocyte, donor3	12233-129G1	15.65	20.39	7.59	0.71	0.24	0.00
mature adipocyte, donor4	12234-129G2	11.32	11.32	6.05	1.32	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.68	20.97	16.44	4.29	0.71	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	0.00	18.05	7.90	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	4.23	12.14	6.80	2.02	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	7.31	12.39	2.86	2.22	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	8.96	1.71	0.85	2.13	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	4.05	13.16	5.57	1.86	0.34	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	6.15	8.28	4.88	1.70	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	7.71	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	5.74	4.31	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	7.14	13.63	5.84	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	5.88	11.61	5.11	2.01	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	6.94	10.86	5.71	1.80	0.41	0.00
medulla oblongata, newborn, donor10223	10361-105F1	5.55	4.86	3.12	0.69	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	6.86	16.61	4.87	1.99	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	20.42	24.70	13.82	0.12	0.49	0.12
melanoma cell line:COLO 679	10514-107E1	61.95	41.26	30.62	2.87	1.58	0.14
melanoma cell line:G-361	10465-106H6	19.82	17.37	13.57	0.81	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	34.37	20.44	22.61	0.72	0.18	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	6.17	4.41	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1.81	5.70	1.56	0.00	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.09	25.93	13.81	0.77	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.27	18.91	11.63	0.18	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.19	22.36	10.35	1.66	0.00	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	39.75	39.75	23.74	1.69	1.26	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	49.68	43.52	34.66	1.93	1.93	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	58.30	55.53	26.37	2.08	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	46.17	33.47	26.60	1.54	0.51	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.28	27.37	19.09	1.15	0.58	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.15	23.48	15.52	1.06	0.66	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	40.38	26.33	20.12	1.22	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.28	21.34	15.08	0.57	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	31.29	16.80	13.83	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	24.63	19.51	12.32	0.97	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	40.49	34.91	27.93	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	41.45	36.34	26.54	0.82	0.41	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	24.44	20.85	12.58	2.88	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	25.45	30.62	16.24	1.34	0.72	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	34.20	27.59	17.33	2.96	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.37	15.94	13.85	0.42	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.36	25.85	20.47	1.49	0.60	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.16	22.06	12.08	0.70	0.70	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	43.07	41.97	35.34	2.95	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	19.74	20.89	1.14	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.89	12.63	7.16	0.42	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	21.92	19.64	12.79	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.67	20.21	9.98	1.28	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	27.22	22.25	12.04	2.62	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.64	17.87	10.78	1.54	0.92	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.89	19.30	7.77	0.94	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	20.31	9.48	2.37	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.76	23.97	14.15	2.36	0.39	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.15	18.07	6.49	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	23.36	20.19	10.96	1.73	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.21	23.87	11.82	1.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.67	16.82	12.02	0.96	0.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	21.27	12.47	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.48	19.47	10.07	1.01	0.67	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.33	20.47	6.96	2.05	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	19.76	5.15	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	27.34	24.61	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	15.49	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.93	19.16	7.79	1.95	0.97	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	21.82	8.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	36.78	20.26	18.66	1.60	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	22.08	9.81	0.82	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.16	23.71	11.27	2.33	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	31.48	14.69	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	28.81	22.85	9.93	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	19.07	19.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	23.13	10.08	1.19	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	21.93	10.97	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	24.07	6.97	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.97	20.69	16.56	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	30.09	25.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	11.98	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	41.33	27.55	10.33	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	33.82	22.41	18.34	1.22	0.81	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	23.83	12.71	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	19.45	22.40	1.77	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.43	23.38	21.20	0.62	0.31	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	14.70	17.38	1.34	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	21.29	11.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	23.11	10.27	2.57	2.57	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.90	28.22	18.59	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	8.91	7.42	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	10.09	7.85	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.09	11.45	3.82	0.64	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	14.91	3.63	1.21	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	10.90	6.54	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	13.94	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	12.74	12.14	6.68	2.43	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	9.04	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	18.94	4.94	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.26	24.80	14.49	1.79	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.33	16.87	12.01	0.32	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	21.39	17.32	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	9.28	13.93	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	24.33	53.63	40.16	3.07	0.94	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.38	36.37	12.28	0.93	1.39	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	17.09	12.82	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	66.38	19.21	21.68	0.82	0.41	0.92
mesothelioma cell line:Mero-25	10850-111F4	13.39	6.35	5.90	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	17.36	19.31	13.20	0.49	0.98	0.73
mesothelioma cell line:Mero-48a	10852-111F6	16.39	15.94	8.19	0.89	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	29.96	16.56	15.51	1.58	0.26	0.79
mesothelioma cell line:Mero-83	10854-111F8	25.87	20.60	13.62	0.17	0.51	1.02
mesothelioma cell line:Mero-84	10855-111F9	19.72	17.44	10.11	1.26	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	23.81	20.91	15.11	0.83	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	25.51	9.94	10.27	0.33	0.00	0.83
mesothelioma cell line:NCI-H226	10846-111E9	39.82	19.19	17.01	1.99	0.36	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	32.11	24.77	19.82	1.37	0.51	0.68
mesothelioma cell line:NCI-H28	10845-111E8	10.43	22.14	7.89	2.80	0.00	0.51
mesothelioma cell line:No36	10857-111G2	19.25	30.01	19.25	1.63	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	55.00	14.36	20.86	1.08	0.54	1.08
migratory langerhans cells, donor1	11901-125F2	6.91	4.80	4.03	0.58	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	7.94	8.67	4.76	0.98	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	10.59	16.33	8.26	1.08	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.58	54.52	38.20	2.61	0.98	6.53
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.28	20.77	25.43	1.70	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	22.58	10.83	11.52	0.00	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	6.28	7.23	4.76	0.57	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	43.43	20.33	21.81	0.74	1.48	0.37
myeloma cell line:PCM6	10474-106I6	18.19	24.51	12.06	1.98	0.79	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.26	7.61	6.59	1.01	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.83	10.79	12.36	0.20	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.27	21.84	16.38	1.23	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.30	17.50	13.90	0.66	0.29	0.22
nasal epithelial cells, donor2	12227-129F4	29.26	16.01	16.56	1.10	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	4.37	9.89	2.53	0.69	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	6.17	14.97	8.79	1.31	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	3.16	10.54	0.84	1.27	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	2.61	11.93	3.73	0.00	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	7.83	2.14	0.95	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	3.96	14.57	4.43	1.27	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	2.01	12.08	2.01	0.60	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	2.54	17.17	4.45	2.54	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	10.91	10.38	7.72	0.00	0.00	0.80
neutrophil PMN, donor1	12133-128D9	44.62	74.37	89.25	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	28.75	34.33	23.00	2.20	1.52	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	37.62	14.41	7.20	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.23	49.05	29.18	1.60	1.92	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	37.84	34.42	16.55	2.10	1.05	1.05
nucleus accumbens, adult, pool1	10037-101F1	5.53	18.84	8.34	2.72	0.47	0.00
occipital cortex - adult, donor10196	10172-103C1	6.18	12.36	4.12	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	6.17	8.86	7.51	1.61	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	6.91	5.10	3.28	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	11.81	4.20	1.84	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	3.43	5.15	6.01	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	3.23	14.90	5.20	1.10	0.24	0.00
olfactory region, adult	10195-103E6	1.72	9.36	3.06	2.10	0.38	0.00
optic nerve, donor1	10277-104E7	0.00	4.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.08	11.96	7.52	0.57	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.18	29.13	7.28	3.30	0.69	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.64	9.82	11.01	1.19	0.85	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.63	14.32	7.62	0.69	0.46	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	18.52	12.64	14.99	0.29	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	21.49	28.96	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	18.45	25.87	13.78	3.82	0.64	0.00
ovary, adult, pool1	10020-101D2	16.95	24.02	12.67	1.57	0.70	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	26.03	15.22	17.97	0.73	0.37	0.37
pancreas, adult, donor1	10049-101G4	17.87	29.16	11.29	1.88	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	35.22	32.15	15.09	1.68	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	42.59	18.23	17.89	0.51	0.00	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.35	9.60	11.43	0.66	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	5.31	15.83	8.05	2.29	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	5.14	8.07	2.94	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	2.82	6.58	2.82	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	4.85	8.84	3.42	2.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	4.76	14.80	7.23	2.03	0.53	0.00
parietal lobe, fetal, donor1	10072-101I9	1.94	4.85	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	7.48	4.49	2.24	0.00	0.00	0.00
parotid gland, adult	10199-103F1	15.42	28.37	11.10	1.23	0.62	0.62
penis, adult	10200-103F2	6.98	15.58	6.45	0.54	1.07	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1.30	14.13	2.05	2.60	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	43.27	27.10	25.64	2.04	1.17	0.87
pineal gland - adult, donor10196	10179-103C8	9.68	10.32	9.68	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	10.66	18.95	5.33	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	8.15	10.66	5.64	1.88	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	21.25	16.19	5.06	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	11.99	37.52	15.64	6.78	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	13.62	25.54	5.96	3.40	0.85	0.85
placenta, adult, pool1	10021-101D3	236.29	75.57	99.76	6.88	2.90	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	6.36	13.38	4.90	1.59	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.37	33.46	26.61	2.02	1.40	0.31
pons, adult, pool1	10033-101E6	5.08	12.31	5.77	1.46	0.26	0.09
postcentral gyrus, adult, pool1	10032-101E5	4.97	14.12	6.71	2.09	0.44	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	66.92	50.19	33.46	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	16.52	16.52	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	46.94	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	23.45	38.75	24.76	2.62	1.02	0.58
prostate cancer cell line:PC-3	10439-106E7	16.70	15.43	8.89	0.36	0.54	0.18
prostate, adult, pool1	10022-101D4	17.96	24.58	12.24	2.27	1.00	0.00
putamen, adult, donor10196	10176-103C5	3.54	16.76	6.37	4.01	0.71	0.00
putamen, adult, donor10252	10152-102I8	7.84	17.65	9.80	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	4.37	2.19	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	4.11	17.15	3.38	3.62	0.48	0.00
putamen, newborn, donor10223	10365-105F5	1.50	1.50	3.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	68.08	32.29	22.69	0.87	0.87	0.00
rectum, fetal, donor1	10067-101I4	6.95	15.30	4.17	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.44	35.62	30.32	0.64	0.64	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	8.28	24.44	19.88	1.66	0.41	0.41
retina, adult, pool1	10030-101E3	17.89	32.21	13.62	3.88	0.80	0.00
retinoblastoma cell line:Y79	10475-106I7	3.90	21.04	6.75	3.12	0.78	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	2.09	12.17	4.92	0.74	0.37	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	5.91	12.09	6.19	1.12	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.95	24.25	15.16	0.76	1.52	0.76
salivary acinar cells, donor1	11771-123I7	6.47	15.38	5.66	0.97	0.32	0.16
salivary acinar cells, donor2	11772-123I8	10.05	20.65	7.85	1.65	0.55	0.41
salivary acinar cells, donor3	11773-123I9	6.62	9.27	8.61	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	27.45	34.32	13.15	5.15	2.29	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.29	30.18	33.72	1.60	0.59	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	45.49	30.56	35.38	1.29	1.29	0.00
seminal vesicle, adult	10201-103F3	6.88	16.93	8.99	1.59	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.30	20.65	11.66	2.92	0.24	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	23.15	13.84	16.61	2.26	1.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	19.07	8.03	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	12.22	25.52	8.46	1.61	0.13	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	79.91	13.82	19.56	0.77	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.26	27.61	19.10	1.16	1.16	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	2.84	2.84	1.42	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	17.99	18.95	12.83	2.04	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	6.03	9.05	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	19.57	15.15	10.73	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	11.34	21.01	10.67	2.67	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	4.73	5.99	6.30	0.00	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	26.79	5.01	6.94	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	10.05	11.70	5.60	0.66	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.34	21.55	3.38	1.93	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	19.39	15.69	8.50	1.53	0.22	0.22
small intestine, adult, pool1	10024-101D6	51.24	28.55	27.35	1.07	0.36	0.00
small intestine, fetal, donor1	10064-101I1	52.82	42.01	29.24	2.46	1.47	3.19
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.87	16.93	14.36	1.03	0.51	2.05
smooth muscle, adult, pool1	10048-101G3	11.11	24.81	8.79	1.03	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	15.55	30.82	12.33	1.88	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	4.82	5.51	3.21	1.38	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	8.67	7.10	5.91	0.79	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	1.38	1.38	0.69	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	9.76	17.08	6.10	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	5.05	8.27	2.76	0.92	0.46	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.01	11.95	7.92	0.30	0.60	0.45
spleen, adult, pool1	10025-101D7	22.80	13.55	12.78	0.66	0.33	0.00
spleen, fetal, pool1	10044-101F8	17.00	11.68	8.90	0.87	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	9.94	16.98	7.76	1.86	0.31	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	6.65	20.32	10.06	1.71	1.33	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.39	22.02	12.58	5.59	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	25.02	14.86	18.76	0.00	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	18.57	9.45	9.23	0.23	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.93	39.82	16.94	3.39	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	30.04	16.08	25.81	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	14.95	18.16	13.88	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	19.37	29.05	12.53	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	7.27	8.93	8.31	1.04	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	4.14	6.72	2.59	4.14	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	9.19	1.41	3.53	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.94	19.49	6.65	4.13	0.92	0.23
temporal lobe, adult, pool1	10031-101E4	3.22	13.05	5.00	2.37	0.59	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.27	3.56	2.85	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.08	3.96	0.44	1.76	0.00	0.00
tenocyte, donor1	11763-123H8	27.93	32.47	17.80	1.75	1.05	1.05
tenocyte, donor2	11765-123I1	46.16	39.68	31.28	0.76	1.91	1.91
tenocyte, donor3	11768-123I4	24.09	24.46	15.94	1.85	0.74	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	5.95	10.20	2.55	1.02	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	6.01	13.26	3.70	0.62	0.46	0.00
teratocarcinoma cell line:PA-1	10807-111A6	12.40	20.46	9.61	1.24	0.62	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.80	20.69	16.00	2.16	0.76	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.21	14.37	4.16	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.74	12.65	8.72	0.33	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.14	15.63	4.89	0.98	0.65	0.33
testis, adult, pool1	10026-101D8	19.22	29.31	15.57	2.36	0.54	0.00
testis, adult, pool2	10096-102C6	6.77	10.37	3.16	2.71	0.45	0.90
thalamus - adult, donor10196	10168-103B6	4.42	6.62	1.10	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	5.16	7.66	5.16	0.63	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	1.54	3.08	1.54	7.70	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	4.45	6.26	4.28	0.66	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	2.88	4.60	1.15	1.15	0.00	0.00
throat, adult	10209-103G2	8.74	14.73	6.74	1.00	0.50	0.00
throat, fetal, donor1	10061-101H7	10.06	19.20	6.09	3.05	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	2.19	9.94	3.18	0.79	0.00	0.00
thymus, adult, pool1	10027-101D9	8.85	11.33	6.56	0.99	0.89	0.00
thymus, fetal, pool1	10043-101F7	12.68	13.51	9.87	0.83	0.52	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.80	16.75	18.61	0.53	0.27	0.93
thyroid carcinoma cell line:TCO-1	10783-110G9	19.84	22.49	16.20	0.42	0.56	0.14
thyroid, adult, pool1	10028-101E1	22.02	49.64	19.13	6.25	1.21	0.28
thyroid, fetal, donor1	10060-101H6	12.66	24.78	11.07	2.11	1.05	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	12.09	13.49	6.74	0.70	0.47	0.23
tongue, fetal, donor1	10059-101H5	9.46	16.55	10.64	0.79	0.39	0.39
tonsil, adult, pool1	10047-101G2	14.22	20.14	10.52	2.00	0.60	0.00
trachea, adult, pool1	10029-101E2	23.64	23.64	14.72	1.55	0.33	0.08
trachea, fetal, donor1	10058-101H4	20.00	24.62	20.77	2.69	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.45	30.11	20.19	0.35	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	19.35	10.84	10.13	0.30	0.30	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.65	36.19	27.89	2.19	1.10	0.78
tridermal teratoma cell line:HGRT	10694-109G1	19.03	26.64	7.61	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.29	11.26	9.73	0.59	0.34	0.08
umbilical cord, fetal, donor1	10057-101H3	22.95	25.04	8.35	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	17.40	24.40	12.46	3.07	0.68	0.00
uterus, fetal, donor1	10055-101H1	25.08	26.11	18.94	1.54	0.51	1.02
vagina, adult	10204-103F6	11.63	17.45	14.86	0.00	0.00	0.00
vein, adult	10191-103E2	14.25	16.22	9.64	0.88	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	4.01	9.61	3.74	0.80	0.53	0.00